Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GobyMeds vs NowPatient

GobyMeds
Graded #131

Higher grade

vs+3.700000000000003
NowPatient
Graded #217

Lower grade

The verdict

GobyMeds takes it — 69.2/100 to 65.5/100.

GobyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Affordable telehealth provider offering compounded semaglutide only.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGobyMeds +33
68
35
Dose & formulationNowPatient +18
75
93
Clinical oversightNowPatient +4
82
86
Labs & monitoringNowPatient +1
53
54
FulfillmentEven
70
70
Contract termsEven
55
55
GobyMeds · left barNowPatient · right bar

The numbers

MetricGobyMedsNowPatient
WeighScore69.2/10065.5/100
GradeCC
Scorecard rank#131#217
Semaglutide$169/mo (all doses, compounded)$1,349/mo (brand Wegovy)
Tirzepatide$299/mo (all doses, compounded)$1,069/mo (brand Mounjaro, promotional rate)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
GobyMeds

Graded #131 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard